Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 68 | Showing Results 1 - 5 of 337

JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial

To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC. Stereotactic Ablative Radiotherapy has been shown in single...

Brian Louie, M.D.
  • Swedish Medical Center

A Randomized, Double-Blind, Placebo-Controlled Pilot of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma)

This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with...

Alison Conlin, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

AM0010-201: A Randomized Phase 2 Trial of AM0010 in Combination with Pembrolizumab vs. Pembrolizumab Alone as First-line Therapy in Patients with Metastatic Non-Small Cell Lung Cancer whose Tumors Have High PD-L1 Expression

This Study provides first-line treatment to patients diagnosed with Non-Small Cell Lung Cancer. There are two arms patients can be randomized to:...

Isaac Tafur, M.D.
  • SJH Texas

SJH 14-096-Alliance A151216- A Genetic Testing for patients with Resectable or resected lung cancer. Adjuvant Lung Cancer enrichment maker identification and sequencing trial (ALCHEMIST )

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by...

Isaac Tafur, M.D.
  • Covenant Medical Center
  • SJH Texas
« Previous 12345 Next »
Viewing Page 1 of 68 | Showing Results 1 - 5 of 337